» Articles » PMID: 9858511

Genetic Control of Natural Killing and in Vivo Tumor Elimination by the Chok Locus

Overview
Journal J Exp Med
Date 1998 Dec 22
PMID 9858511
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The molecular mechanisms underlying target recognition during natural killing are not well understood. One approach to dissect the complexities of natural killer (NK) cell recognition is through exploitation of genetic differences among inbred mouse strains. In this study, we determined that interleukin 2-activated BALB/c-derived NK cells could not lyse Chinese hamster ovary (CHO) cells as efficiently as C57BL/6-derived NK cells, despite equivalent capacity to kill other targets. This strain-determined difference was also exhibited by freshly isolated NK cells, and was determined to be independent of host major histocompatibility haplotype. Furthermore, CHO killing did not correlate with expression of NK1.1 or 2B4 activation molecules. Genetic mapping studies revealed linkage between the locus influencing CHO killing, termed Chok, and loci encoded within the NK gene complex (NKC), suggesting that Chok encodes an NK cell receptor specific for CHO cells. In vivo assays recapitulated the in vitro data, and both studies determined that Chok regulates an NK perforin-dependent cytotoxic process. These results may have implications for the role of NK cells in xenograft rejection. Our genetic analysis suggests Chok is a single locus that affects NK cell-mediated cytotoxicity similar to other NKC loci that also regulate the complex activity of NK cells.

Citing Articles

Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells.

Foerster F, Boegel S, Heck R, Pickert G, Russel N, Rosigkeit S Oncoimmunology. 2018; 7(4):e1409929.

PMID: 29632723 PMC: 5889278. DOI: 10.1080/2162402X.2017.1409929.


Deficiency of the adaptor protein SLy1 results in a natural killer cell ribosomopathy affecting tumor clearance.

Arefanian S, Schall D, Chang S, Ghasemi R, Higashikubo R, Zheleznyak A Oncoimmunology. 2017; 5(12):e1238543.

PMID: 28123874 PMC: 5215235. DOI: 10.1080/2162402X.2016.1238543.


Genetic dissection of NK cell responses.

Moussa P, Marton J, Vidal S, Fodil-Cornu N Front Immunol. 2013; 3:425.

PMID: 23346087 PMC: 3548222. DOI: 10.3389/fimmu.2012.00425.


Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice.

Rocha F, Chaves K, Chammas R, Peron J, Rizzo L, Schor N Cancer Immunol Immunother. 2010; 59(9):1357-65.

PMID: 20490489 PMC: 11030630. DOI: 10.1007/s00262-010-0865-6.


Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1.

Carayannopoulos L, Barks J, Yokoyama W, Riley J Biol Reprod. 2010; 83(3):404-14.

PMID: 20484740 PMC: 2924803. DOI: 10.1095/biolreprod.110.084509.


References
1.
TRENTIN J, Rauchwerger J, Gallagher M . Genetic resistance to marrow transplantation. Biomedicine. 1973; 18(2):86-8. View

2.
Ryan J, Niemi E, Nakamura M, Seaman W . NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med. 1995; 181(5):1911-5. PMC: 2191987. DOI: 10.1084/jem.181.5.1911. View

3.
Kaufman C, Gaines B, Ildstad S . Xenotransplantation. Annu Rev Immunol. 1995; 13:339-67. DOI: 10.1146/annurev.iy.13.040195.002011. View

4.
Mason L, Ortaldo J, Young H, Kumar V, Bennett M, Anderson S . Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J Exp Med. 1995; 182(2):293-303. PMC: 2192132. DOI: 10.1084/jem.182.2.293. View

5.
Stoneman E, Bennett M, An J, Chesnut K, Wakeland E, Scheerer J . Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med. 1995; 182(2):305-13. PMC: 2192143. DOI: 10.1084/jem.182.2.305. View